Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > The Closing Price Is Deceptive

<< Previous

Bullboard Posts

Next >>

Post by blinkieon Jan 07, 2021 6:56pm

209 Views

Post# 32250564

The Closing Price Is Deceptive

If you just checked the closing price today and saw it down $0.01 you might get discouraged.

Look again.

The heavily weighted Bis is $0.055. There will always be. that small gap from between $0.055 & $0.06.

Any kind of news will change all of that.

In the meantime the big boys will keep accumulating!,

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks